TNFSF10 and respiratory tract infectious disorder: In fact, TRAIL has been reported to be a critical determinant for promoting the development of chronic lung disease in early life (196); targeting TRAIL by genetic deletion or neutralizing antibody application in early-life respiratory infections ameliorated infection-induced histopathology, inflammation, as well as emphysema-like alveolar enlargement and lung function.